rs1554554233
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_002485.5(NBN):c.2232delT(p.Phe744LeufsTer7) variant causes a frameshift, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002485.5 frameshift, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1456926Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 725088
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Microcephaly, normal intelligence and immunodeficiency Uncertain:2
This sequence change deletes 1 nucleotide from exon 15 of the NBN mRNA (c.2232delT), causing a frameshift at codon 744. This creates a premature translational stop signal in the last exon of the NBN mRNA (p.Phe744Leufs*7). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 11 amino acids of the NBN protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an NBN-related disease. Experimental studies have not been reported for this truncating variant and it is currently unknown if the last 11 amino acids of the NBN protein are critical for its function. In summary, this is a novel truncation with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at